Skip to main content
Signal8

Evofem Biosciences, Inc. (EVFM) AI Dilution Summary

Updated Nov 14, 2026

Cash was $317,000 at 2026-09-30, the last balance-sheet date. Two dated obligations follow it: the Adjuvant Notes at $34,600,000 and the Exchanged Senior Subordinated Notes at $9,700,000, both due 2026-12-01. Dilution here is driven primarily by the $22,500,000 Adjuvant Notes.